ARTICLE | Clinical News
Sovaldi Sofosbuvir/velpatasvir: Phase III data
September 28, 2015 7:00 AM UTC
Top-line data from the open-label, international Phase III ASTRAL-3 trial in 552 patients with chronic HCV genotype 3 infection showed that a fixed-dose oral combination of once-daily 400 mg Sovaldi s...